Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05ff905fdc49089f5f25746eaeb40190 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 |
filingDate |
1997-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2003-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9717d946849ccb9683628f8c48080e9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb6ecc81281e71e5f5beeb5eaa33e883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f41c1a59e3b5c256572f889df453f5f8 |
publicationDate |
2003-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-522012-B |
titleOfInvention |
Denaturants for sympathomimetic amine salts |
abstract |
The present invention is directed to the addition of one or more pharmaceutically and biologically acceptable denaturants to sympathomimetic amine salt-containing pharmaceutical products to make these products less suitable as starting materials for the production of illegal drugs. In one preferred embodiment, the denaturant(s) and the sympathomimetic amine salt exhibit similar chemical and/or physical properties, so that purification of sympathomimetic amine by conventional extraction techniques is rendered difficult or essentially infeasible. In another preferred embodiment, the denaturant physically interferes with the extraction of the sympathomimetic amine salt from the pharmaceutical products (i.e., emulsifies and/or alters the viscosity of the pharmaceutical products in solution). Because the separation of denaturant(s) from the sympathomimetic amine salts is rendered impracticable, attempts to isolate the sympathomimetic amine salts from compositions of the invention are unsuccessful or results in preparations that are converted into adulterated illegal drug products. The present invention is directed to denaturant-containing sympathomimetic amine products and to methods for their preparation. The denaturant-containing sympathomimetic amine products are used for known indications treated by sympathomimetic amines. |
priorityDate |
1996-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |